Results 1 to 10 of about 85,254 (227)

Update on the second-line treatment of infection: a narrative review

open access: yesTherapeutic Advances in Gastroenterology, 2023
A standard bismuth quadruple therapy, a fluoroquinolone-containing triple (or quadruple) therapy or a proton pump inhibitor (PPI)-amoxicillin high-dose dual therapy has been recommended as a second-line treatment for Helicobacter pylori infection by the ...
Chih-An Shih   +5 more
doaj   +1 more source

Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results [PDF]

open access: yesТерапевтический архив, 2020
Aim. Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian Federation. Materials and methods. As part of a clinical laboratory study, from 2015 to 2018,
I. V. Maev   +15 more
doaj   +1 more source

Synthesis a Number of Heterocyclic Compounds and some of chalcones Derived From Levofloxacin

open access: yesTikrit Journal of Pure Science, 2023
The hydrazide (1) was used as synthone for the following Compound pyridazine-3,6-dione (2) by reaction of hydrazide (1) with maleic  anhydride and Compound phthalazine-1,4-dione (3) by the reaction of  hydrazide (1) with phthalic anhydride.
Ekram Abdullah Basheer   +2 more
doaj   +1 more source

Numerical Mechanistic Modelling of Drug Release from Solvent-Removal Zein-Based In Situ Gel

open access: yesPharmaceutics, 2023
The development of effective drug delivery systems remains a focus of extensive research to enhance therapeutic outcomes. Among these, in situ forming gels (ISG) have emerged as a promising avenue for controlled drug release. This research focuses on the
Setthapong Senarat   +4 more
doaj   +1 more source

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

open access: yes, 2017
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
ALVARO, Domenico   +16 more
core   +8 more sources

Controlled Levofloxacin Release and Antibacterial Properties of β-Cyclodextrins-Grafted Polypropylene Mesh Devices for Hernia Repair. [PDF]

open access: yes, 2018
Mesh infection is a major complication of hernia repair. After knitted mesh implantation, bacteria can grow within textile structures causing infection.
Li, Yan   +6 more
core   +3 more sources

Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations. [PDF]

open access: yes, 2019
Fluoroquinolones represent the pillar of multidrug-resistant tuberculosis (MDR-TB) treatment, with moxifloxacin, levofloxacin, or gatifloxacin being prescribed to MDR-TB patients.
Alvarez-Cabrera, Nadine   +16 more
core   +2 more sources

Adsorption of Levofloxacin on Microplastics in Aqueous Solution [PDF]

open access: yes대한환경공학회지, 2022
Objectives Recently, microplastics (MPs) is observed at surface water in worldwide because of massive use of plastics. Since MPs have a large specific surface area, they could provide adsorption sites to water contaminants such as Levofloxacin (LVF). LVF
Jooyoung Lee, Jeong-Ann Park
doaj   +1 more source

Current development of Helicobacter pylori eradication protocols

open access: yesИнфекция и иммунитет, 2022
H. pylori is one of the most common commensal microorganisms in the human body, colonizing up to 60% of the inhabitants of all continents. Some strains of H.
A. O. Pozdeeva   +4 more
doaj   +1 more source

Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid

open access: yesAntibiotics, 2019
Neurotoxicity is a rare and intolerable adverse effect associated with levofloxacin therapy, whose diagnosis has mostly been reported based on medical history rather than quantitative measures in the blood.
Masashi Nishikubo   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy